APA (7th ed.) Citation

A, A., G, N., T, C., MW, T., MJ, G., GP, A., . . . RD, R. (2025). Monitoring for 5-aminosalicylate nephrotoxicity in adults with inflammatory bowel disease: Prognostic model development and validation using data from the Clinical Practice Research Datalink. BMJ open gastroenterology, 12(1), . https://doi.org/10.1136/bmjgast-2024-001627

Chicago Style (17th ed.) Citation

A, Abhishek, Nakafero G, Card T, Taal MW, Grainge MJ, Aithal GP, Mallen CD, Stevenson MD, and Riley RD. "Monitoring for 5-aminosalicylate Nephrotoxicity in Adults with Inflammatory Bowel Disease: Prognostic Model Development and Validation Using Data from the Clinical Practice Research Datalink." BMJ Open Gastroenterology 12, no. 1 (2025). https://doi.org/10.1136/bmjgast-2024-001627.

MLA (9th ed.) Citation

A, Abhishek, et al. "Monitoring for 5-aminosalicylate Nephrotoxicity in Adults with Inflammatory Bowel Disease: Prognostic Model Development and Validation Using Data from the Clinical Practice Research Datalink." BMJ Open Gastroenterology, vol. 12, no. 1, 2025, https://doi.org/10.1136/bmjgast-2024-001627.